> Molecular Templates a biopharmaceutical company developing what it calls a new class of small biologic therapies called Engineered Toxin Bodies has entered into a research collaboration with Alnylam Pharmaceuticals, which will evaluate and develop Molecular Templates' technology for targeted delivery of RNAi therapies. No financial terms were disclosed. Release
> PolyPid has introduced a new family of drug carriers based on a melding of two drug delivery systems: polymers and lipid-based systems. The PolyPid carrier carrier can be tailored to small molecules, peptides, protein and nucleic acids-based drugs. Story
> Acrux receives boost from Europe for drug delivery technology for dogs. Item
> Independent clinical study validates Nanologica's new drug carrier material for oral use. Nanologica release